Jing Liu

发表

Soft fibrin gels promote selection and growth of tumourigenic cells

Jing Liu, Yi Zhang, Ning Wang, 2012, Nature Materials.

Mechanism of alternative splicing and its regulation (Review)

Yanmei Xu, Jing Li, Jing Liu, 2015 .

Microparticles released by Listeria monocytogenes-infected macrophages are required for dendritic cell-elicited protective immunity

R. Schwendener, H. Xiong, M. Cui, 2012, Cellular and Molecular Immunology.

Low dosages: new chemotherapeutic weapons on the battlefield of immune-related disease

Jing Liu, Liang Hu, Bo Huang, 2011, Cellular and Molecular Immunology.

K562 cell-derived exosomes suppress the adhesive function of bone marrow mesenchymal stem cells via delivery of miR-711.

Yanmei Xu, Cui Zhao, Jing Li, 2020, Biochemical and biophysical research communications.

Heat shock protein 10 (Hsp10) in immune-related diseases: one coin, two sides.

Jing Liu, H. Jia, Liang Hu, 2011, International journal of biochemistry and molecular biology.

Analysis of maturation dynamics and developmental competence of in vitro matured oocytes under time-lapse monitoring

Jing Liu, Bo Huang, Qiyu Yang, 2021, Reproductive Biology and Endocrinology.

Alternative splicing of apoptosis-related genes in imatinib-treated K562 cells identified by exon array analysis

Jing Li, Jing Liu, Bo Huang, 2011, International journal of molecular medicine.

Mast cell: insight into remodeling a tumor microenvironment

Foad Katirai, Jing Liu, Yi Zhang, 2011, Cancer and Metastasis Reviews.

Imatinib regulates the alternative pre-mRNA splicing of Bcl-x in K562 cells

Jing Li, Jing Liu, Bo Huang, 2012 .

A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia

Jing Liu, Zhuoxin Sun, Bo Huang, 2022, Lipids in Health and Disease.

Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer

Yanmei Xu, Jing Liu, Bo Huang, 2017, Oncotarget.

Jing Zhang, Jing Liu, Bo Huang, 2022, Frontiers in Oncology.

Aberrant Expression of Splicing Factors in Newly Diagnosed Acute Myeloid Leukemia

Jing Li, Jing Liu, Bo Huang, 2012, Oncology Research and Treatment.

Upregulation of cytosolic phosphoenolpyruvate carboxykinase is a critical metabolic event in melanoma cells that repopulate tumors.

Xiaoyu Liang, Jing Liu, Hua-Chuan Zhang, 2015, Cancer research.

Jing Liu, Bo Huang, Xiaozhong Wang, 2022, Scientific Reports.

Transcriptome profiling reveals the high incidence of hnRNPA1 exon 8 inclusion in chronic myeloid leukemia

Yanmei Xu, Jing Li, Jing Liu, 2020, Journal of advanced research.

Exosomes: Novel Biomarkers for Clinical Diagnosis

Yanmei Xu, Jing Li, Jing Liu, 2015, TheScientificWorldJournal.

Depletion of Regulatory T Cells Facilitates Growth of Established Tumors: A Mechanism Involving the Regulation of Myeloid-Derived Suppressor Cells by Lipoxin A4

D. Ye, G. Shen, Jing Liu, 2010, The Journal of Immunology.

A LipoxinMyeloid-Derived Suppressor Cells by Mechanism Involving the Regulation of Growth of Established Tumors : A Depletion of Regulatory T Cells Facilitates

D. Ye, G. Shen, Jing Liu, 2010 .

Association Between TNF-α -308G/A Polymorphism and Risk of Immune Thrombocytopenia: A Meta-Analysis.

Yanmei Xu, Jing Li, Jing Liu, 2017, Genetic testing and molecular biomarkers.

A Pooling Genome-Wide Association Study Identifies Susceptibility Loci and Signaling Pathways of Immune Thrombocytopenia in Chinese Han Population

Xiaoli Tang, Yanmei Xu, Libin Deng, 2020, International journal of genomics.

Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia

Cui Zhao, Jing Liu, Bo Huang, 2022, PeerJ.

Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients

Cui Zhao, Jing Liu, Bo Huang, 2021, Frontiers in Oncology.

Innate Immune Cell–Derived Microparticles Facilitate Hepatocarcinoma Metastasis by Transferring Integrin αMβ2 to Tumor Cells

D. Ye, G. Shen, Foad Katirai, 2013, The Journal of Immunology.

Mechanism of alternative splicing and its regulation.

Yan Wang, Jing Li, Jing Zhang, 2015, Biomedical reports.

Exosomes derived from imatinib‐resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug‐resistant trait by delivering miR‐365

Yanmei Xu, Jing Li, Jing Liu, 2018, Experimental cell research.

Differential expression and alternative splicing of cell cycle genes in imatinib-treated K562 cells

Yanmei Xu, Jing Li, Jing Liu, 2015, Tumor Biology.

Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia

Jing Liu, Bo Huang, Xiao-zhong Wang, 2023, Journal of Translational Medicine.

Differential expression of urinary exosomal microRNAs in IgA nephropathy

Yanmei Xu, Jing Li, Jing Liu, 2018, Journal of clinical laboratory analysis.

Differential miRNA expression in pleural effusions derived from extracellular vesicles of patients with lung cancer, pulmonary tuberculosis, or pneumonia

Yanmei Xu, Jing Li, Jing Liu, 2016, Tumor Biology.

Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions

Yanmei Xu, Jing Li, Jing Liu, 2017, Medicine.

TLR4 signaling induces the release of microparticles by tumor cells that regulate inflammatory cytokine IL-6 of macrophages via microRNA let-7b

Jing Liu, Hua-Chuan Zhang, Yi Zhang, 2012, Oncoimmunology.

Delivery of chemotherapeutic drugs in tumour cell-derived microparticles

Guimei Zhang, Jing Liu, Yi Zhang, 2012, Nature Communications.

Is differences in embryo morphokinetic development significantly associated with human embryo sex?†

Na Guo, Jing Liu, Wen Chen, 2018, Biology of reproduction.

Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia

Yanmei Xu, Jing Liu, Bo Huang, 2023, Cancer Cell International.

Selective miRNA expression profile in chronic myeloid leukemia K562 cell-derived exosomes.

Yanmei Xu, Jing Li, Jing Liu, 2013, Asian Pacific journal of cancer prevention : APJCP.

Therapeutic Use of Tumor Cell-Derived Extracellular Vesicles.

Jing Liu, K. Tang, Bo Huang, 2017, Methods in molecular biology.

m(6)A Modification of lncRNA NEAT1 Regulates Chronic Myelocytic Leukemia Progression via miR-766-5p/CDKN1A Axis

Cui Zhao, Jing Liu, Bo Huang, 2021, Frontiers in Oncology.

Correction of Bcl‐x splicing improves responses to imatinib in chronic myeloid leukaemia cells and mouse models

Yuehua Wu, Yanmei Xu, Jing Li, 2020, British journal of haematology.

Hepatic Symbiotic Bacterium L. reuteri FLRE5K1 Inhibits the Development and Progression of Hepatocellular Carcinoma via Activating the IFN-γ/CXCL10/CXCR3 Pathway.

Jing Liu, Bo Huang, Feng Xu, 2023, Probiotics and antimicrobial proteins.

The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy

Yanmei Xu, Jing Liu, Bo Huang, 2023, Genes and Diseases.

Identification of cellular senescence-related signature for predicting prognosis and therapeutic response of acute myeloid leukemia.

Jing Liu, Bo Huang, Xiao-zhong Wang, 2023, Aging.

Development and validation of a disulfidptosis-related scoring system to predict clinical outcome and immunotherapy response in acute myeloid leukemia by integrated analysis of single-cell and bulk RNA-sequencing

Jing Liu, Bo Huang, Junyao Jiang, 2023, Frontiers in pharmacology.

Bioinformatic analysis of the expression profile and identification of RhoGDI2 as a biomarker in imatinib-resistant K562 cells

Yanmei Xu, Jing Liu, Bo Huang, 2023, Hematology.